Ticagrelor Impurity L (Mixture of Diastereomers)
 
		Product Description
CAT No.
				
									ALN-T023006								
				CAS No.
				
									NA								
				Mol. F.
				
									C23H28F2N6O5S								
				Mol. Wt.
				
									538.6								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : (1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol								
				
									Smiles : OCCO[C@H]1C[C@@H](N2C(N=C(S(CCC)=O)N=C3N[C@H]4[C@@H](C5=CC=C(F)C(F)=C5)C4)=C3N=N2)[C@H](O)[C@@H]1O								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method
									By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.nFrom World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.								
				Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies
									By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav – From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724 								
				Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)
									By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara – From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            